Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

96.88
-1.1000-1.12%
Post-market: 96.39-0.4937-0.51%19:59 EDT
Volume:7.30M
Turnover:711.25M
Market Cap:17.65B
PE:-16.46
High:100.00
Open:96.70
Low:96.39
Close:97.98
Loading ...

BRIEF-Insmed Announces Positive Topline Results From Phase 2B Study Of Its Blood Pressure Drug

Reuters
·
10 Jun

Insmed's blood pressure drug meets main goal in mid-stage trial

Reuters
·
10 Jun

Insmed’s Inhalation Powder meets endpoints in Phase 2b PAH trial

TIPRANKS
·
10 Jun

Insmed Inc. Announces Positive Phase 2b Study Results for TPIP in PAH, Plans Phase 3 Trials for PH-ILD and PAH by 2026

Reuters
·
10 Jun

Insmed Inc - Results Show Sustained Benefit Throughout 24-Hour Dosing Period

THOMSON REUTERS
·
10 Jun

Insmed Inc - to Engage With FDA for Phase 3 Trial Design

THOMSON REUTERS
·
10 Jun

Insmed Inc - 35% Placebo-Adj Reduction in Pulmonary Vascular Resistance

THOMSON REUTERS
·
10 Jun

Insmed Inc: Study Met Primary and All Secondary Efficacy Endpoints

THOMSON REUTERS
·
10 Jun

Insmed: Plans to Initiate Phase 3 Trial in Patients With Ph-Ild Before End of 2025 and Phase 3 Trial in Patients With Pah in Early 2026

THOMSON REUTERS
·
10 Jun

Insmed Announces Positive Topline Results From Phase 2B Study of Treprostinil Palmitil Inhalation Powder (Tpip) as Once-Daily Therapy in Patients With Pulmonary Arterial Hypertension

THOMSON REUTERS
·
10 Jun

Promising Phase 2 Data and Market Potential Drive Buy Rating for Insmed’s TPIP in PAH Treatment

TIPRANKS
·
09 Jun

Insmed Inc. Completes Redemption of Convertible Senior Notes Due 2028

Reuters
·
07 Jun

Michael Alexander Smith, Chief Legal Officer, Reports Disposal of Insmed Inc. Common Shares

Reuters
·
07 Jun

Chief Medical Officer Martina Flammer Reports Disposal of Insmed Inc. Common Shares

Reuters
·
05 Jun

Sara Bonstein, CFO of Insmed Inc., Reports Disposal of Common Shares

Reuters
·
05 Jun

Nicole Schaeffer Orlov, Chief People Strategy Officer, Reports Disposal of Common Shares of Insmed Inc

Reuters
·
05 Jun

William Lewis, Chair and CEO of Insmed Inc., Reports Disposal of Common Shares

Reuters
·
05 Jun

Insmed Inc. Announces Inducement Grants for 150 New Employees Under 2025 Compensation Plan

Reuters
·
05 Jun

Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Jun

Leerink Partners Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
04 Jun